Patients with locally advanced pancreatic cancer have a new treatment option. The FDA recently approved Optune Pax, a wearable device that delivers tumor-treating fields (TTFields) to disrupt cancer cell division…
Patients with locally advanced pancreatic cancer have a new treatment option. The FDA recently approved Optune Pax, a wearable device that delivers tumor-treating fields (TTFields) to disrupt cancer cell division…